Treatment of rheumatoid Arthritis in Practice - a Comparison of Tocilizumab vs. TNF-Inhibitors (CONSENS)

被引：0
|
作者：
Backhaus, M. [1 ]
Kaufmann, J.
Richter, C.
Vollmer, M.
Volberg, C. [2 ]
Wassenberg, S. [3 ]
Roske, A. [4 ]
Hellmann, P. [5 ]
Gaubitz, M. [6 ]
机构：
[1] Charite, Med Klin Schwerpunkt Rheumatol & Klin Immunol, D-13353 Berlin, Germany
[2] Rheumazentrum Neuss, Neuss, Germany
[3] Evangel Fachkrankenhaus, Rheumazentrum Ratingen, Rheumatol Klin, Ratingen, Germany
[4] Roche Pharma AG, Grenzach Wyhlen, Germany
[5] Chugai Pharma Mkt Ltd, Frankfurt, Germany
[6] WWU Munster, Akad Manuelle Therapie, Munster, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：119 / 120
页数：2
相关论文
共 50 条
  • [41] RITUXIMAB AND TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    Gonzalez-Vacarezza, Nicolas
    Aleman, Alicia
    Gonzalez, Graciela
    Perez, Ana
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2014, 30 (03) : 282 - 288
  • [42] Tocilizumab in the treatment of rheumatoid arthritis and beyond
    Shetty, Anjali
    Hanson, Rebekah
    Korsten, Peter
    Shawagfeh, Munir
    Arami, Shiva
    Volkov, Suncica
    Vila, Olga
    Swedler, William
    Shunaigat, Abdel Naser
    Smadi, Sameer
    Sawaqed, Ray
    Perkins, David
    Shahrara, Shiva
    Sweiss, Nadera J.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 349 - 364
  • [43] Subcutaneous tocilizumab for the treatment of rheumatoid arthritis
    Mitchell, Emma
    Jones, Graeme
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (02) : 103 - 114
  • [44] Tocilizumab in the treatment of adult rheumatoid arthritis
    Sanmarti, Raimon
    Ruiz-Esquide, Virginia
    Bastida, Carla
    Soy, Dolor
    [J]. IMMUNOTHERAPY, 2018, 10 (06) : 447 - 464
  • [45] Review of tocilizumab in the treatment of rheumatoid arthritis
    Okuda, Yasuaki
    [J]. BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01): : 75 - 82
  • [46] CLINICAL EFFICACY OF TNF INHIBITORS AND ABATACEPT IN JAPANESE RHEUMATOID ARTHRITIS PATIENTS SWITCHING FROM TOCILIZUMAB
    Hirabara, S.
    Kojima, T.
    Takahashi, N.
    Yabe, Y.
    Kaneko, A.
    Kida, D.
    Hirano, Y.
    Ishiguro, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1057 - 1058
  • [47] OVERALL CANCER RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNF INHIBITORS, TOCILIZUMAB, ABATACEPT, OR RITUXIMAB
    Wadstrom, H.
    Frisell, T.
    Askling, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 93 - 93
  • [48] SECUKINUMAB IS DOMINANT VS. TNF-INHIBITORS IN THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS: RESULTS FROM A TURKISH COST-EFFECTIVENESS MODEL
    Sarioz, R.
    Ozdemir, O.
    Direk, S.
    Sezen, Cavusoglu S.
    Barutcugil, M.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A534 - A534
  • [49] Ustekinumab and TNF-inhibitors in the treatment of moderate to severe psoriasis
    Garcia Lopez, Isabel
    Herranz Alonso, Ana
    Rodriguez Gonzalez, Carmen Guadelupe
    Castillo Romera, Isabel
    Pernia Lopez, Sagrario
    Sanjurjo Saez, M.
    [J]. EJHP PRACTICE, 2011, 17 (01): : 46 - 50
  • [50] Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis
    Leslie R. Harrold
    George W. Reed
    Jennie Best
    Steve Zlotnick
    Joel M. Kremer
    [J]. Rheumatology and Therapy, 2018, 5 : 507 - 523
12345